With an individual company enjoying dominance, the facial injectables market in North America exhibits a monopolistic vendor landscape. In 2016, Allergan Plc., held the dominant share of 62% in the North America facial injectables market and is expected to remain the leading company through the forecast period. Its dominance is attributable to the strong brand value of its drugs such as Juvederm and Botox. Of these, Botox currently witnesses the highest demand and the trend is unlikely to change until 2024, finds Transparency Market Research (TMR) in a new study.
According to TMR, the North America market for facial injectables is likely to showcase a CAGR of 12.0% between 2016 and 2024. At this pace, the market will reach US$5.8 bn by 2024, as compared to its value of US2.1 bn in 2015.
U.S. to Continue Dominating North America Facial Injectables Market
By geography, the U.S. and Canada is at the fore of the North America facial injectables market. Among these nations, the U.S. held dominance as it exhibits a considerably high demands for botulinum toxins and dermal fillers. High living standards and demand for enhancing facial features through minimally invasive methods have catapulted the U.S. to the fore of the North America facial injectables market.
Based on product, hyaluronic acid, collagen, botulinum toxin, and polymer fillers constitute the key market segments. Of these, botulinum toxin held the largest share in the North America facial injectables market. It is predominantly used to correct lines, wrinkles, and creases. The botulinum toxin segment is forecast to exhibit a CAGR of 12.7% between 2016 and 2024.
Long-lasting Effects Achieved from Synthetic Injectables to Bolster Growth Opportunities
Synthetic products are nowadays developed using polymers and particles, which has considerably upped the demand for facial injectables in North America. These novel products are liked more by consumers as they boast a longer shelf-life, which helps consumers push the need for re-treatment farther. Furthermore, the rising availability of facial injectables, which offer permanent effects, is also enabling growth in the North America facial injectables market. Also as innovations are brought to reduce frequency of the treatment, the cost incurred on facial injectables is reduced, making the procedure more affordable, thus fuelling their demand.
The facial injectables market is raking high profit in North America also against the backdrop of the paradigm shift toward minimally invasive surgeries. The market will therefore gain as minimally invasive surgeries gain prominence in dermatological applications. Changing lifestyle choices, rising disposable income, and alternating standard of beauty and attractiveness will therefore emerge as key growth drivers.
Possibility of Side-effects from Using Facial Injectables to Hamper Growth
On the downside, using facial injectables exposes a person to potential allergic reaction, as the procedure often involves the use of living organisms and related enzymes and chemicals, which can hamper the market’s trajectory to an extent. Furthermore, side-effects such as bruising, bleeding, and edema are also expected limit the scope for the market’s expansion. Poor reimbursement policies for procedures involving facial injectables also stall the market’s growth.
This review is based on a TMR report, titled “Facial Injectables Market (Product - Botulinum Toxin, Hyaluronic Acid, Collagen, (Porcine/Bovine-based and Human-based), Particle & Polymer Fillers (PPF) (Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid, and Calcium Hydroxyapatite; Treatment - Facial Pain, Wrinkle Treatment, and Lip Augmentation; End User - Hospitals, Ambulatory Surgical Centers, Cosmetic Centers, Dermatology Clinics, and Physician Clinics) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The report segments the North America facial injectables market as:
North America Facial Injectables Market, by Product Type
- Botulinum Toxin
- Hyaluronic Acid
- Porcine/ Bovine-Based
- Human Based
- Particle & Polymer Fillers (PPF)
- Polymethylmethacrylate Beads (PMMA microspheres)
- Poly-L-Lactic Acid
- Calcium Hydroxyapatite
North America Facial Injectables Market, by Treatment
- Facial Pain
- Wrinkle Treatment
- Lip Augmentation
North America Facial Injectables Market, by End User
- Ambulatory Surgical Centers
- Cosmetic Centers
- Dermatology Clinics
- Physician Clinics
North America Facial Injectables Market, by Country
- North America
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453